» Articles » PMID: 21735044

Design and Validation of an Endothelial Progenitor Cell Capture Chip and Its Application in Patients with Pulmonary Arterial Hypertension

Overview
Specialty General Medicine
Date 2011 Jul 8
PMID 21735044
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The number of circulating endothelial progenitor cells (EPCs) inversely correlates with cardiovascular risk and clinical outcome, and thus has been proposed as a valuable biomarker for risk assessment, disease progression, and response to therapy. However, current strategies for isolation of these rare cells are limited to complex, laborious approaches. The goal of this study was the design and validation of a disposable microfluidic platform capable of selectively capturing and enumerating EPCs directly from human whole blood in healthy and diseased subjects, eliminating sample preprocessing. We then applied the "EPC capture chip" clinically and determined EPC numbers in blood from patients with pulmonary arterial hypertension (PAH). Blood was collected in tubes and injected into polymeric microfluidic chips containing microcolumns pre-coated with anti-CD34 antibody. Captured cells were immunofluorescently stained for the expression of stem and endothelial antigens, identified and counted. The EPC capture chip was validated with conventional flow cytometry counts (r = 0.83). The inter- and intra-day reliability of the microfluidic devices was confirmed at different time points in triplicates over 1-5 months. In a cohort of 43 patients with three forms of PAH (idiopathic/heritable, drug-induced, and connective tissue disease), EPC numbers are ≈50% lower in PAH subjects vs. matched controls and inversely related to two potential disease modifiers: body mass index and postmenopausal status. The EPC capture chip (5 × 30 × 0.05 mm(3)) requires only 200 μL of human blood and has the strong potential to serve as a rapid bedside test for the screening and monitoring of patients with PAH and other proliferative cardiovascular, pulmonary, malignant, and neurodegenerative diseases.

Citing Articles

Stem cell therapy in pulmonary hypertension: current practice and future opportunities.

Zheng R, Xu T, Wang X, Yang L, Wang J, Huang X Eur Respir Rev. 2023; 32(169).

PMID: 37758272 PMC: 10523152. DOI: 10.1183/16000617.0112-2023.


Organ Chips and Visualization of Biological Systems.

Tian T, Liu J, Zhu H Adv Exp Med Biol. 2023; 1199:155-183.

PMID: 37460731 DOI: 10.1007/978-981-32-9902-3_8.


Endothelial progenitor cell mobilization based on exercise volume in patients with cardiovascular disease and healthy individuals: a systematic review and meta-analysis.

Mitsiou G, Tokmakidis S, Dinas P, Smilios I, Nanas S Eur Heart J Open. 2022; 2(6):oeac078.

PMID: 36583078 PMC: 9793853. DOI: 10.1093/ehjopen/oeac078.


Therapeutic Potential of Endothelial Progenitor Cells in Pulmonary Diseases.

Kolesnichenko O, Whitsett J, Kalin T, Kalinichenko V Am J Respir Cell Mol Biol. 2021; 65(5):473-488.

PMID: 34293272 PMC: 8641852. DOI: 10.1165/rcmb.2021-0152TR.


Progenitor/Stem Cells in Vascular Remodeling during Pulmonary Arterial Hypertension.

Dierick F, Solinc J, Bignard J, Soubrier F, Nadaud S Cells. 2021; 10(6).

PMID: 34071347 PMC: 8226806. DOI: 10.3390/cells10061338.


References
1.
Diller G, Thum T, Wilkins M, Wharton J . Endothelial progenitor cells in pulmonary arterial hypertension. Trends Cardiovasc Med. 2010; 20(1):22-9. DOI: 10.1016/j.tcm.2010.03.003. View

2.
Hill J, Zalos G, Halcox J, Schenke W, Waclawiw M, Quyyumi A . Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003; 348(7):593-600. DOI: 10.1056/NEJMoa022287. View

3.
Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T . Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997; 275(5302):964-7. DOI: 10.1126/science.275.5302.964. View

4.
Gleghorn J, Pratt E, Denning D, Liu H, Bander N, Tagawa S . Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody. Lab Chip. 2009; 10(1):27-9. PMC: 3031459. DOI: 10.1039/b917959c. View

5.
Hansmann G, Wagner R, Schellong S, de Jesus Perez V, Urashima T, Wang L . Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation. 2007; 115(10):1275-84. DOI: 10.1161/CIRCULATIONAHA.106.663120. View